Atlas Trials

MK2206 in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer

Clinical trial NCT01319539 · TERMINATED

Trial details

NCT number
NCT01319539
Sponsor
National Cancer Institute (NCI)
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Estrogen Receptor NegativeEstrogen Receptor PositiveHER2/Neu NegativeHER2/Neu PositiveProgesterone Receptor NegativeProgesterone Receptor PositiveStage IA Breast CancerStage IB Breast CancerStage IIA Breast CancerStage IIB Breast CancerStage IIIA Breast CancerStage IIIB Breast Cancer
Start date
2011-04-01
Primary completion
2013-07-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.